SynthesisMedicine2017

Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy: A meta-analysis of 15 randomized controlled trials.

Min Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.